| Literature DB >> 30755627 |
Daowan Lai1, Jiajia Meng1, Dan Xu1, Xuping Zhang1, Yafeng Liang2, Yu Han2, Cong Jiang2, Huiquan Liu2, Chenfang Wang2, Ligang Zhou3, Jin-Rong Xu4,5.
Abstract
Ustilaginoidins are a kind of mycotoxins with 9,9'-linked bis-naphtho-γ-pyrones structures produced by the rice false smut pathogen Villosiclava virens. These metabolites displayed a wide range of bioactivities, such as teratogenic, cytotoxic, phytotoxic, and antibacterial activities. So far 26 ustilaginoidins have been isolated from V. virens, among which 18 compounds contained stereogenic center(s), however, most of them were unknown for the absolute configurations, except that of ustilaginoidin D. In this study, the absolute structures of these ustilaginoidins were constructed for the first time by analysis of the biosynthetic monomers obtained from a gene knockout mutant (ΔUV_2091) of V. virens. The gene UV_2091 was predicted to encode an enzyme that dimerized the monomeric naphtho-γ-pyrones in V. virens. Knockout of this gene led to the accumulation of three monomers, namely hemiustilaginoidin F (1), epihemiustilaginoidin D (2), and hemiustilaginoidin D (3), but the production of ustilaginoidins was completely blocked. The structures of the monomers were deduced by spectroscopic analysis, in combination with TDDFT ECD calculations for determining the absolute configurations. These compounds were tested for their phytotoxic, cytotoxic, antibacterial, and antifungal activities. Compounds 1 and 3 showed inhibition against the radicle and plumule elongation of rice and lettuce seeds at the tested concentrations. Compound 1 was active against the tested five human cancer cells, with half maximal inhibitory concentrations (IC50s) of 13.2~37.3 μM. Compounds 1~3 inhibited the growth of the tested pathogenic bacteria with minimum inhibitory concentrations of 8~32 µg/mL, while compound 3 exhibited antifungal activity against Magnaporthe oryzae (IC50, 5.21 µg/mL). A comparison of these data with those of the ustilaginoidins provided insights into the structure-bioactivity relationships.Entities:
Year: 2019 PMID: 30755627 PMCID: PMC6372653 DOI: 10.1038/s41598-018-37941-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Different substitution patterns of the monomeric building blocks of the ustilaginoidins containing a 2,3-dihydropyran-4-one moiety.
Figure 2HPLC analysis of the EtOAc extracts obtained from the wild type and the ΔUV_2091 mutant strain. The peaks observed between 23~34 min in the wild type corresponding to ustilaginoidins F, G, E, O, N, D and M, respectively.
1H and 13C NMR data of 1~3.
| Position | 1 (CD3OD) | 2 (CD3COCD3) | 3 (CD3OD) | |||
|---|---|---|---|---|---|---|
| 2 | 74.7, CH | 4.50, ddq (11.0, 3.6, 6.2) | 76.4, CH | 4.68, qd (6.5, 3.2) | 79.5, CH | 4.14, dq (10.6, 6.2) |
| 3 | 44.3, CH2 | 2.78, dd (17.4, 11.0) | 45.0, CH | 2.82, qd (7.3, 3.2) | 47.4, CH | 2.66, dq (10.6, 7.0) |
| 2.70, dd (17.4, 3.6) | ||||||
| 4 | 199.7, C | 203.2, C | 201.9, C | |||
| 4a | 103.2, C | 102.27, C | 102.5, C | |||
| 5 | 165.5, C | NDa | 165.2, C | |||
| 5a | 105.2, C | 104.8, C | 105.2, C | |||
| 6 | 160.9, C | 160.5 C | 160.8, C | |||
| 7 | 101.0, CH | 6.19, br.s | 100.8, CH | 6.28, d (2.1) | 100.9, CH | 6.18, d (2.0) |
| 8 | 163.4, C | 163.2, C | 163.2, C | |||
| 9 | 102.5, CH | 6.37, d (1.6) | 102.33, CH | 6.53, d (2.1) | 102.3, CHb | 6.354, d (2.0) |
| 9a | 143.9, C | 143.6, C | 143.8, C | |||
| 10 | 101.9, CH | 6.39, s | 101.5, CH | 6.46, s | 101.8, CHb | 6.348, s |
| 10a | 156.7, C | 155.8, C | 156.4, C | |||
| 2-CH3 | 21.2, CH3 | 1.46, d (6.2) | 16.7, CH3 | 1.39, d (6.5) | 20.0, CH3 | 1.46, d (6.2) |
| 3-CH3 | 9.8, CH3 | 1.21, d (7.3) | 10.4, CH3 | 1.22, d (7.0) | ||
aND: not detected.
bAssignments within a column may be interchanged.
Figure 3The experimental ECD spectrum of 3, and the calculated ECD spectrum of (2R, 3R)-3.
Figure 4The experimental ECD spectrum of 1, and the calculated ECD spectrum of (2R)-1.
Figure 5The experimental ECD spectrum of 2, and the calculated ECD spectra of (2R, 3S)-2, and (2S, 3R)-2.
Figure 6Proposed absolute structures for the ustilaginoidins mentioned in Figure S1.
Phytotoxic activities of 1 and 3 on radicle and plumule growth of rice and lettuce seeds.
| Compound | Concentration (µg/mL) | Inhibition ratio of radicle growth (%)a | Inhibition ratio of plumule growth (%)a | ||||
|---|---|---|---|---|---|---|---|
|
| 50 | 22.28 ± 1.03 h | 7.62 ± 2.56 h | 21.57 ± 2.12 h | 9.28 ± 3.37 f | 5.45 ± 1.16 e | 6.94 ± 2.02 f |
| 100 | 30.58 ± 1.80 g | 33.89 ± 1.91 g | 33.97 ± 2.57 f | 10.95 ± 5.73 f | 5.45 ± 2.57 e | 13.65 ± 0.57 e | |
| 200 | 35.81 ± 0.66 f | 43.81 ± 5.19 f | 41.91 ± 3.35 e | 14.40 ± 0.85 ef | 10.41 ± 1.35 e | 19.69 ± 2.01 d | |
| 400 | 52.20 ± 4.83 d | 53.57 ± 1.68 e | 100.00 ± 0.00 a | 14.43 ± 1.54 ef | 11.59 ± 0.71 e | 100.00 ± 0.00 a | |
|
| 50 | 21.88 ± 0.76 h | 51.43 ± 1.35 e | 11.47 ± 2.24 j | 19.56 ± 5.72 de | 21.82 ± 5.14 d | 4.88 ± 0.12 f |
| 100 | 27.26 ± 2.29 g | 55.71 ± 2.02 e | 15.82 ± 2.96 i | 22.32 ± 0.14 de | 34.09 ± 3.21 c | 14.44 ± 2.29 e | |
| 200 | 46.12 ± 1.52 e | 62.70 ± 1.12 d | 27.26 ± 2.00 g | 23.37 ± 6.23 d | 35.00 ± 4.50 c | 20.53 ± 2.70 d | |
| 400 | 49.35 ± 1.52 de | 75.24 ± 4.04 c | 100.00 ± 0.00 a | 24.40 ± 2.81 d | 35.91 ± 5.79 c | 100.00 ± 0.00 a | |
| Glyphosate (positive control) | 50 | 88.47 ± 1.11 c | 89.19 ± 0.13 b | 75.92 ± 2.80 d | 47.15 ± 3.33 c | 57.14 ± 3.67 b | 18.51 ± 0.77 d |
| 100 | 93.45 ± 0.32 b | 89.50 ± 0.98 b | 77.41 ± 3.59 cd | 59.29 ± 0.33 b | 59.09 ± 2.57 b | 27.63 ± 0.95 c | |
| 200 | 97.03 ± 3.03 ab | 95.43 ± 1.14 a | 80.23 ± 1.77 bc | 60.73 ± 1.33 a | 63.64 ± 1.29 ab | 28.80 ± 2.43 c | |
| 400 | 98.64 ± 0.36 a | 98.07 ± 0.17 a | 82.97 ± 1.53 b | 70.73 ± 1.33 a | 68.18 ± 2.57 a | 56.81 ± 3.65 b | |
aThe values were expressed as means ± SD (n = 3). Different letters indicated significant differences among treatments in each column at p ≤ 0.05.
Cytotoxicities of 1 and 3 (IC50, μM).
| Compound | HCT116 | NCI-H1650 | BGC823 | Daoy | HepG2 |
|---|---|---|---|---|---|
|
| 13.2 | 25.3 | 21.4 | 37.3 | 13.6 |
|
| >50.0 | >50.0 | >50.0 | >50.0 | >50.0 |
| Taxol (positive control) | 0.0019 | 1.1 | 0.000107 | 0.00504 | 0.0146 |
Antibacterial activities of 1~3.
| Bacterium | MIC/IC50 (µg/mL) | Compound | |||
|---|---|---|---|---|---|
| 1 | 2 | 3 | Streptomycin sulfatea | ||
| MIC | 16 | 16 | 32 | 32 | |
| IC50 | 7.44 | 8.85 | 12.70 | 9.70 | |
| MIC | 16 | 32 | 32 | 32 | |
| IC50 | 7.66 | 10.25 | 8.66 | 3.48 | |
| MIC | 8 | 16 | 16 | 8 | |
| IC50 | 5.75 | 8.72 | 7.44 | 5.59 | |
| MIC | 8 | 8 | 16 | 8 | |
| IC50 | 4.75 | 4.21 | 6.26 | 2.30 | |
| MIC | 32 | 32 | 32 | 32 | |
| IC50 | 10.61 | 20.99 | 10.69 | 6.56 | |
| MIC | 16 | 32 | 16 | 16 | |
| IC50 | 8.13 | 15.37 | 6.86 | 6.16 | |
aPositive control.